Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) (TAK) closed at $21.43 on November 13, 2026, up 1.5% from the previous close, on volume of 3,636,549 shares (30-day average 2,882,408).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Takeda Updates Real-World Crohn’s Disease Study as Investors Watch Darvadstrocel Data
TipRanks (Thu, 12-Nov 11:32 AM ET)
Takeda Updates Real-World Study of Maribavir in Transplant Patients
TipRanks (Thu, 12-Nov 11:32 AM ET)
Takeda Updates Real-World TAKHZYRO Study in Hereditary Angioedema
TipRanks (Thu, 12-Nov 11:32 AM ET)
Takeda launches new narcolepsy pill as DEA completes scheduling
Seeking Alpha News (Thu, 12-Nov 8:42 AM ET)
Business Wire (Thu, 12-Nov 7:35 AM ET)
Takeda spotlights ORZEYFUL approvals and raises FY2026 forecast as reported operating profit jumps
Market Chameleon (Fri, 30-Oct 7:53 AM ET)
Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones
Business Wire (Thu, 29-Oct 2:36 AM ET)
Business Wire (Fri, 23-Oct 7:30 AM ET)
Business Wire (Mon, 19-Oct 5:30 AM ET)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) trades on the NYSE stock market under the symbol TAK.
As of November 13, 2026, TAK stock price climbed to $21.43 with 3,636,549 million shares trading.
TAK has a beta of -0.03, meaning it tends to be less sensitive to market movements. TAK has a correlation of 0.00 to the broad based SPY ETF.
TAK has a market cap of $68.44 billion. This is considered a Large Cap stock.
Last quarter Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) reported $7 billion in Revenue and $.48 earnings per share. This beat revenue expectation by $267 million and exceeded earnings estimates by $.17.
In the last 3 years, TAK traded as high as $21.73 and as low as $12.58.
The top ETF exchange traded funds that TAK belongs to (by Net Assets): FVD, PPH, AVDE, IDVO, APIE.
TAK has outperformed the market in the last year with a price return of +50.5% while the SPY ETF gained +13.4%. TAK has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +23.2% and +2.5%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
TAK support price is $20.76 and resistance is $21.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TAK shares will trade within this expected range on the day.
